![](https://savarapharma.com/wp-content/uploads/page-header-blue-ridges-m.jpg)
![](https://savarapharma.com/wp-content/uploads/page-header-blue-ridges-d.jpg)
Filing
Table of Contents
As filed with the Securities and Exchange Commission on June 25, 2008
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM S-8
REGISTRATION STATEMENT UNDER
THE SECURITIES ACT OF 1933
THE SECURITIES ACT OF 1933
ADVENTRX PHARMACEUTICALS, INC.
(Exact Name of Registrant as Specified in its Charter)
Delaware (State or Other Jurisdiction of Incorporation or Organization) |
84-1318182 (I.R.S. Employer Identification No.) |
6725 Mesa Ridge Road, Suite 100, San Diego, CA 92121
(Address of Principal Executive Offices)
(Address of Principal Executive Offices)
2005 EQUITY INCENTIVE PLAN
2005 EMPLOYEE STOCK PURCHASE PLAN
2008 OMNIBUS INCENTIVE PLAN
(Full Title of the Plans)
2005 EMPLOYEE STOCK PURCHASE PLAN
2008 OMNIBUS INCENTIVE PLAN
(Full Title of the Plans)
Evan M. Levine
Chief Executive Officer and President
ADVENTRX Pharmaceuticals, Inc.
6725 Mesa Ridge Road, Suite 100
San Diego, CA 92121
(Name and Address of Agent For Service)
Chief Executive Officer and President
ADVENTRX Pharmaceuticals, Inc.
6725 Mesa Ridge Road, Suite 100
San Diego, CA 92121
(Name and Address of Agent For Service)
(858) 552-0866
(Telephone Number, Including Area Code, of Agent For Service)
(Telephone Number, Including Area Code, of Agent For Service)
Copies to:
Patrick L. Keran General Counsel, Secretary and Vice President, Legal ADVENTRX Pharmaceuticals, Inc. 6725 Mesa Ridge Road, Suite 100 San Diego, CA 92121 Telephone: (858) 552-0866 Facsimile: (858) 552-0876 |
Michael S. Kagnoff DLA Piper US LLP 4365 Executive Drive, Suite 1100 San Diego, CA 92121 Telephone: (858) 677-1400 Facsimile: (858) 677-1401 |
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated
filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act.
(Check one):
Large accelerated filer o | Accelerated filer þ | Non-accelerated filer o | Smaller reporting company o | |||
(Do not check if a smaller reporting company) |
CALCULATION OF REGISTRATION FEE
Amount | Proposed maximum | Proposed maximum | Amount | |||||||||||
to be | offering price | aggregate offering | of | |||||||||||
Title of securities to be registered | registered (1) | per share (2) | price (2) | registration fee | ||||||||||
Common Stock, $0.001 par value per |
783,376 | $0.395 | $309,433.52 | $12.16 | ||||||||||
share, to be issued pursuant to the |
(3)(4) | |||||||||||||
2005 Equity Incentive Plan |
||||||||||||||
Common Stock, $0.001 par value per |
2,173,634 | $0.395 | $858,585.43 | $33.74 | ||||||||||
share, to be issued pursuant to the |
(5) | |||||||||||||
2005 Employee Stock Purchase Plan |
||||||||||||||
Common Stock, $0.001 par value per |
13,097,500 | $0.395 | $5,173,512.50 | $203.32 | ||||||||||
share, to be issued pursuant to the
|
||||||||||||||
2008 Omnibus Incentive Plan |
||||||||||||||
Aggregate registration fee: | $249.22 | |||||||||||||
(1) | Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the Securities Act), this registration statement also covers an indeterminate number of additional shares that may be issued in connection with a stock split, stock dividend or similar capital adjustment, as required by the plans. | |
(2) | This estimate is computed in accordance with Rule 457(h) under the Securities Act solely for the purpose of calculating the registration fee, and is based on the average of the high and low prices of the registrants common stock on June 20, 2008, as reported by the American Stock Exchange. | |
(3) | Represents (a) 673,634 shares automatically added to the shares authorized for issuance under the ADVENTRX Pharmaceuticals, Inc. 2005 Equity Incentive Plan (the 2005 EIP) on January 1, 2006, and (b) 109,742 shares automatically added to the shares authorized for issuance under the 2005 EIP on January 1, 2007, all pursuant to the evergreen provision contained in the 2005 EIP. | |
(4) | Shares subject to awards granted under the 2005 EIP that are forfeited or expire or settled for cash may, to the extent of such forfeiture, expiration or cash settlement, become available for issuance under the ADVENTRX Pharmaceuticals, Inc. 2008 Omnibus Incentive Plan (the 2008 OIP) pursuant to the terms of the 2008 OIP. | |
(5) | Represents (a) 673,634 shares automatically added to the shares authorized for issuance under the ADVENTRX Pharmaceuticals, Inc. 2005 Employee Stock Purchase Plan (the 2005 ESPP) on January 1, 2006, (b) 750,000 shares automatically added to the shares authorized for issuance under the 2005 ESPP on January 1, 2007, and (c) 750,000 shares automatically added to the shares authorized for issuance under the 2005 ESPP on January 1, 2008, all pursuant to the evergreen provision contained in the 2005 ESPP. |
TABLE OF CONTENTS
Table of Contents
EXPLANATORY NOTE
This registration statement is being filed for the purpose of registering (1) additional shares of
common stock of ADVENTRX Pharmaceuticals, Inc. (the Registrant) issuable pursuant to the
Registrants 2005 Equity Incentive Plan and 2005 Employee Stock Purchase Plan, and (2) shares of
common stock of the Registrant issuable under the Registrants 2008 Omnibus Incentive Plan. A
registration statement on Form S-8 (File No. 333-126551) was filed with the Securities and Exchange
Commission (the Commission) on July 13, 2005 (the 2005 Form
S-8) to register shares of common stock initially available for issuance under the Registrants 2005 Equity Incentive Plan and 2005 Employee Stock Purchase Plan and it is effective. In accordance with General Instruction E to Form S-8, the contents of the 2005 Form S-8 are incorporated by reference in this registration statement.
S-8) to register shares of common stock initially available for issuance under the Registrants 2005 Equity Incentive Plan and 2005 Employee Stock Purchase Plan and it is effective. In accordance with General Instruction E to Form S-8, the contents of the 2005 Form S-8 are incorporated by reference in this registration statement.
The 2008 Omnibus Incentive Plan was approved by the stockholders of the Registrant on May 28, 2008
and became effective on such date. After May 28, 2008, no awards may be granted under the 2005
Equity Incentive Plan. Pursuant to the terms of the 2008 Omnibus Incentive Plan, shares subject to
awards granted under the 2005 Equity Incentive Plan that are forfeited or expire or settled for
cash may, to the extent of such forfeiture, expiration or cash settlement, become available for
issuance under the 2008 Omnibus Incentive Plan pursuant to the terms of the 2008 Omnibus Incentive
Plan.
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3. Incorporation of Documents by Reference.
The following documents filed with the Commission by the Registrant are incorporated by
reference in this registration statement:
(a) The Registrants Annual Report on Form 10-K for the fiscal year ended December 31, 2007,
as filed on March 17, 2008;
(b) The Registrants Quarterly Report on Form 10-Q for the fiscal quarter ended March 31,
2008, as filed on May 12, 2008;
(c) The Registrants Current Reports on Form 8-K, as filed on January 14, 2008, January 30,
2008, February 25, 2008, March 6, 2008, March 25, 2008, April 4, 2008, April 7, 2008, April 16,
2008, June 2, 2008 and June 3, 2008; and
(d) The description of the Registrants common stock contained in the Registrants
registration statement on Form 8-A (File No. 001-32157) filed April 27, 2004, including any
amendment or report for the purposes of updating such description.
All documents subsequently filed by the Registrant pursuant to Sections 13(a), 13(c), 14 and
15(d) of the Securities Exchange Act of 1934 (the Exchange Act), prior to the filing of a
post-effective amendment to this registration statement which indicates that all of the shares of
common stock offered under this registration statement have been sold or which deregisters all of
such shares then remaining unsold, are incorporated by reference in this registration statement and
are a part hereof from the date of the filing of such documents, except as to any portion of any
future annual, quarterly or current report or document that is not deemed filed with the
Commission. Any statement contained in a document incorporated or deemed to be incorporated by
reference herein shall be deemed to be modified or superseded for purposes of this registration
statement to the extent that a statement contained herein or in any other subsequently filed
document which also is or is deemed to be incorporated by reference herein modifies or supersedes
such statement. Any such statement so modified or superseded shall not be deemed, except as so
modified or superseded, to constitute a part of this registration statement.
1
Table of Contents
Item 4. Description of Securities.
Not applicable.
Item 5. Interests of Named Experts and Counsel.
Not applicable.
Item 6. Indemnification of Directors and Officers.
Section 145 of the Delaware General Corporation Law authorizes a corporation to indemnify its
directors and officers against liabilities arising out of actions, suits and proceedings to which
they are made or threatened to be made a party by reason of the fact of their prior or current
service to the Company as a director or officer, in accordance with the provisions of Section 145,
which are sufficiently broad to permit indemnification under certain circumstances for liabilities
arising under the Securities Act of 1933, as amended (the Securities Act). The indemnity may
cover expenses (including attorneys fees) judgments, fines and amounts paid in settlement actually
and reasonably incurred by the director or officer in connection with any such action, suit or
proceeding. Section 145 permits corporations to pay expenses (including attorneys fees) incurred
by directors and officers in advance of the final disposition of such action, suit or proceeding.
In addition, Section 145 provides that a corporation has the power to purchase and maintain
insurance on behalf of its directors and officers against any liability asserted against them and
incurred by them in their capacity as a director or officer, or arising out of their status as
such, whether or not the corporation would have the power to indemnify the director or officer
against such liability under Section 145.
The Registrants certificate of incorporation provides that, to the fullest extent permitted
by the Delaware General Corporation Law, (1) a director shall not be personally liable to the
Registrant or its stockholders for monetary damages for breach of fiduciary duty as a director, and
(2) the Registrant shall indemnify any director or officer made a party to an action or proceeding,
whether criminal, civil, administrative or investigative, by reason of the fact of such persons
current or prior service as a director or officer of the Registrant, any predecessor of the
Registrant or any other enterprise per the Registrants or any predecessor to the Registrants
request.
The Registrants bylaws provide that (a) it shall indemnify its directors and officers to the
maximum extent and in the manner permitted by the Delaware General Corporation Law against expenses
(including attorneys fees), judgments, fines, ERISA excise taxes, settlements and other amounts
actually and reasonably incurred in connection with any proceeding, whether civil, criminal,
administrative or investigative, arising by reason of the fact that such person is or was an agent
of the corporation, subject to certain limited exceptions, (b) it shall advance expenses incurred
by any director or officer prior to the final disposition of any proceeding to which the director
or officer was or is or is threatened to be made a party promptly following a request therefore,
subject to certain limited exceptions, and (c) the rights conferred in the Registrants bylaws are
not exclusive.
The Registrant has entered into indemnification agreements with each of its directors and
executive officers to give such directors and officers additional contractual assurances regarding
the scope of the indemnification set forth in the Registrants certificate of incorporation and
bylaws and to provide additional procedural protections. These agreements, among other things,
provide that the Registrant will indemnify its directors and executive officers for expenses
(including attorneys fees), judgments, fines, penalties and amounts paid in settlement (including
all interest, assessments and other charges paid or payable in connection therewith) actually and
reasonably incurred by a director or executive officer in connection with any action or proceeding
to which such person was, is or is threatened to be made a party, a witness or other participant by
reason of such persons services as a director or executive officer of the Registrant, any of the
Registrants subsidiaries or any other company or enterprise to which the person provides services
at the Registrants request, and any federal, state, local or foreign taxes imposed on the director
or executive officer as a result of the actual or deemed receipt of any payments under the
indemnification agreements.
2
Table of Contents
In addition, the indemnification agreements provide that, upon the request of a director or
executive officer, the Registrant shall advance expenses (including attorneys fees) to the
director or officer. The Registrant intends to enter into indemnification agreements with any new
directors and executive officers in the future.
In addition, Alexander J. Denner, a director of the Registrant, is further indemnified against
liabilities arising in connection with his services as a director of the Registrant through his
employment arrangement with entities controlled by Mr. Carl C. Icahn. Such indemnification may be
broader than the indemnification provided by the Delaware General Corporation Law and includes
indemnification for expenses (including attorneys fees), judgments and fines incurred and amounts
paid in settlement by Dr. Denner in connection with any action or proceeding to which Dr. Denner
was, is or is threatened to be made a party or participant by reason of his services as a director
the Registrant.
The Registrant has also obtained an insurance policy covering its directors and officers with
respect to certain liabilities, including liabilities arising under the Securities Act.
Item 7. Exemption from Registration Claimed.
Not Applicable.
Item 8. Exhibits.
Exhibit | ||
Number | Description | |
4.1(1)
|
Form of Registration Rights Agreement entered into in October and November 2001 (including the original schedule of holders) | |
4.2(2)
|
$2.50 Warrant to Purchase Common Stock issued on April 12, 2002 to Emisphere Technologies, Inc. | |
4.3(1)
|
Form of $0.60 Warrant to Purchase Common Stock issued May 28, 2003 (including the original schedule of holders) | |
4.4(1)
|
Form of $1.25 Warrant to Purchase Common Stock issued between October 15, 2003 and December 29, 2003 (including the original schedule of holders) | |
4.5(1)
|
Common Stock and Warrant Purchase Agreement, dated as of April 5, 2004, among the Registrant and the Investors (as defined therein) | |
4.6(1)
|
Registration Rights Agreement, dated April 5, 2004, among the Registrant and the Investors (as defined therein) | |
4.7(1)
|
Form of $2.00 A-1 Warrant to Purchase Common Stock issued April 8, 2004 (including the original schedule of holders) | |
4.8(1)
|
Form of $2.50 A-2 Warrant to Purchase Common Stock issued April 8, 2004 (including the original schedule of holders) | |
4.9(3)
|
Common Stock and Warrant Purchase Agreement, dated April 8, 2004, between the Registrant and CD Investment Partners, Ltd. | |
4.10(3)
|
Registration Rights Agreement, dated April 8, 2004, between the Registrant and CD Investment Partners, Ltd. |
3
Table of Contents
Exhibit | ||
Number | Description | |
4.11(3)
|
$2.00 A-1 Warrant to Purchase Common Stock issued on April 8, 2004 to CD Investment Partners, Ltd. | |
4.12(3)
|
$2.00 A-1 Warrant to Purchase Common Stock issued on April 8, 2004 to Burnham Hill Partners | |
4.13(3)
|
$2.00 A-1 Warrant to Purchase Common Stock issued on April 8, 2004 to Ernest Pernet | |
4.14(3)
|
$2.00 A-1 Warrant to Purchase Common Stock issued on April 8, 2004 to W.R. Hambrecht + Co., LLC | |
4.15(4)
|
Common Stock and Warrant Purchase Agreement, dated April 19, 2004, between the Registrant and Franklin M. Berger | |
4.16(4)
|
Registration Rights Agreement, dated April 19, 2004, between the Registrant and Franklin M. Berger | |
4.17(4)
|
$2.00 A-1 Warrant to Purchase Common Stock issued on April 19, 2004 to Franklin M. Berger | |
4.18(5)
|
Securities Purchase Agreement, dated July 21, 2005, among the Registrant and the Purchasers (as defined therein) | |
4.19(5)
|
Rights Agreement, dated July 27, 2005, among the Registrant, the Icahn Purchasers and Viking (each as defined therein) | |
4.20(6)
|
First Amendment to Rights Agreement, dated September 22, 2006, among the Registrant and the Icahn Purchasers (as defined therein) | |
4.21(7)
|
Second Amendment to Rights Agreement, dated February 25, 2008, among the Registrant and the Icahn Purchasers (as defined therein) | |
4.21(5)
|
Form of $2.26 Common Stock Warrant issued on July 27, 2005 (including the original schedule of holders) | |
4.22(5)
|
Form of $2.26 Common Stock Warrant issued on July 27, 2005 (including the original schedule of holders) | |
4.23(8)
|
$0.50 Warrant (WC-291) to Purchase Common Stock transferred on June 15, 2005 to S. Neborsky and R Neborsky TTEE Robert J. Neborsky MD Inc Comb Retirement Trust | |
4.24(9)
|
$0.50 Warrant (WC-292) to Purchase Common Stock transferred on June 15, 2005 to S. Neborsky and R Neborsky TTEE Robert J. Neborsky MD Inc Comb Retirement Trust | |
4.25(9)
|
$2.50 Warrant to Purchase Common Stock issued on October 22, 2004 to Thomas J. DePetrillo | |
5.1
|
Opinion of DLA Piper US LLP | |
23.1
|
Consent of DLA Piper US LLP (included in Exhibit 5.1) | |
23.2
|
Consent of J.H. Cohn LLP, Independent Registered Public Accounting Firm | |
24.1
|
Powers of Attorney (included on signature page) |
4
Table of Contents
Exhibit | ||
Number | Description | |
99.1#(8)
|
2005 Equity Incentive Plan | |
99.2#(10)
|
Form of Stock Option Agreement under the 2005 Equity Incentive Plan | |
99.3#(11)
|
Form of Stock Option Agreement under the 2005 Equity Incentive Plan (for director option grants beginning in 2008) | |
99.4#(12)
|
Form of Restricted Share Award Agreement under the 2005 Equity Incentive Plan | |
99.5#(13)
|
Form of Stock Option Agreement under the 2005 Equity Incentive Plan (for option grants to employees approved in March 2008) | |
99.6#(10)
|
2005 Employee Stock Purchase Plan | |
99.7#(10)
|
Form of Subscription Agreement under the 2005 Employee Stock Purchase Plan | |
99.8#(14)
|
2008 Omnibus Incentive Plan |
(1) | Filed with the Registrants Registration Statement on Form S-3 on June 30, 2004 (SEC file number 333-117022-03848890). | |
(2) | Filed with the Registrants Amendment No. 1 to Quarterly Report on Form 10-Q/A on October 30, 2006 (SEC file number 001-32157-061170484). | |
(3) | Filed with the Registrants Current Report on Form 8-K/A on April 13, 2004 (SEC file number 000-33219-04730584). | |
(4) | Filed with the Registrants Quarterly Report on Form 10-QSB on May 12, 2004 (001-32157-04797806). | |
(5) | Filed with the Registrants Quarterly Report on Form 10-Q on August 12, 2005 (SEC file number 001-32157-051022046). | |
(6) | Filed with the Registrants Current Report on Form 8-K on September 22, 2006 (SEC file number 001-32157-061103268). | |
(7) | Filed with the Registrants Current Report on Form 8-K on February 25, 2008 (SEC file number 001-32157-08638638). | |
(8) | Filed with the Registrants Annual Report on Form 10-K on March 15, 2007 (SEC file number 001-32157-07697283). | |
(9) | Filed with the Registrants Registration Statement on Form S-3 on August 26, 2005 (SEC file number 333-127857-051050073). | |
(10) | Filed with the Registrants Registration Statement on Form S-8 on July 13, 2005 (SEC file number 333-126551-05951362). |
5
Table of Contents
(11) | Filed with the Registrants Annual Report on Form 10-K on March 17, 2008 (SEC file number 001-32157-08690952). | |
(12) | Filed with the Registrants Annual Report on Form 10-K on March 16, 2006 (SEC file number 001-32157-06693266). | |
(13) | Filed with the Registrants Quarterly Report on Form 10-Q on May 12, 2008 (SEC file number 001-32157-08820541). | |
(14) | Filed with the Registrants Current Report on Form 8-K on June 2, 2008 (SEC file number 001-32157- 08874724). | |
# | Indicates management contract or compensatory plan. |
Item 9. Undertakings
(a) The undersigned Registrant hereby undertakes:
(1) To file, during any period in which offers or sales are being made, a post-effective
amendment to this registration statement:
(i) To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;
(ii) To reflect in the prospectus any facts or events arising after the effective date of this
registration statement (or the most recent post-effective amendment thereof) which, individually or
in aggregate, represent a fundamental change in the information set forth in this registration
statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered
(if the total dollar value of securities offered would not exceed that which was registered) and
any deviation from the low or high end of the estimated maximum offering range may be reflected in
the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the
changes in volume and price represent no more than 20 percent change in the maximum aggregate
offering price set forth in the Calculation of Registration Fee table in the effective registration
statement; and
(iii) To include any material information with respect to the plan of distribution not
previously disclosed in this registration statement or any material change to such information in
this registration statement;
Provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the information
required to be included in a post-effective amendment by those paragraphs is contained in reports
filed with or furnished to the Commission by the Registrant pursuant to Section 13 or Section 15(d)
of the Securities Exchange Act of 1934 that are incorporated by reference in this registration
statement.
(2) That, for the purpose of determining any liability under the Securities Act of 1933, each
such post-effective amendment shall be deemed to be a new registration statement relating to the
securities offered therein, and the offering of such securities at that time shall be deemed to be
the initial bona fide offering thereof.
(3) To remove from registration by means of a post-effective amendment any of the securities
being registered which remain unsold at the termination of the offering.
(4) That, for the purpose of determining liability of the Registrant under the Securities Act
of 1933 to any purchaser in the initial distribution of the securities: The undersigned Registrant
undertakes that in a primary offering of securities of the undersigned Registrant pursuant to this
registration statement, regardless of the underwriting method used to sell the securities to the
purchaser, if the securities are offered or sold to such purchaser
6
Table of Contents
by means of any of the following communications, the undersigned Registrant will be a seller
to the purchaser and will be considered to offer or sell such securities to such purchaser:
(i) Any preliminary prospectus or prospectus of the undersigned Registrant relating to the
offering required to be filed pursuant to Rule 424;
(ii) Any free writing prospectus relating to the offering prepared by or on behalf of the
undersigned Registrant or used or referred to by the undersigned Registrant;
(iii) The portion of any other free writing prospectus relating to the offering containing
material information about the undersigned Registrant or its securities provided by or on behalf of
the undersigned Registrant; and
(iv) Any other communication that is an offer in the offering made by the undersigned
Registrant to the purchaser.
(b) The undersigned Registrant hereby further undertakes that, for purposes of determining any
liability under the Securities Act of 1933, each filing of the Registrants annual report pursuant
to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each
filing of any employee benefit plans annual report pursuant to Section 15(d) of the Securities
Exchange Act of 1934) that is incorporated by reference in this registration statement shall be
deemed to be a new registration statement relating to the securities offered herein, and the
offering of such securities at that time shall be deemed to be the initial bona fide offering
thereof.
(c) Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be
permitted to directors, officers and controlling persons of the Registrant pursuant to the
provisions summarized in Item 6 above, or otherwise, the Registrant has been advised that in the
opinion of the Securities and Exchange Commission such indemnification is against public policy as
expressed in the Securities Act of 1933 and is, therefore, unenforceable. In the event that a
claim for indemnification against such liabilities (other than the payment by the Registrant of
expenses incurred or paid by a director, officer or controlling person of the Registrant in the
successful defense of any action, suit or proceeding) is asserted by such director, officer or
controlling person in connection with the securities being registered, the Registrant will, unless
in the opinion of its counsel the matter has been settled by controlling precedent, submit to a
court of appropriate jurisdiction the question whether such indemnification by it is against public
policy as expressed in the Securities Act of 1933 and will be governed by the final adjudication of
such issue.
7
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it
has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and
has duly caused this registration statement to be signed on its behalf by the undersigned,
thereunto duly authorized, in the City of San Diego, State of California, on this 25th day of June,
2008.
ADVENTRX PHARMACEUTICALS, INC. |
||||
By: | /s/ Evan M. Levine | |||
Evan M. Levine | ||||
Chief Executive Officer and President | ||||
POWER OF ATTORNEY
We, the undersigned directors and/or officers of ADVENTRX Pharmaceuticals, Inc. (the Registrant),
hereby severally constitute and appoint Evan M. Levine, Chief Executive Officer and President, and
Mark N.K. Bagnall, Chief Financial Officer and Executive Vice President, and each of them
individually, with full powers of substitution and resubstitution, our true and lawful attorneys,
with full powers to them and each of them to sign for us, in our names and in the capacities
indicated below, any and all amendments to this registration statement on Form S-8 filed (including
post-effective amendments), together with all exhibits thereto and other documents in connection
therewith, with the Securities and Exchange Commission, granting unto said attorneys, and each of
them, full power and authority to do and perform each and every act and thing requisite and
necessary to be done in connection therewith, as fully to all intents and purposes as each of them
might or could do in person, and hereby ratifying and confirming all that said attorneys, and each
of them, or their substitute or substitutes, shall do or cause to be done by virtue of this Power
of Attorney.
Pursuant to the requirements of the Securities Act of 1933, this registration statement has been
signed below by the following persons in the capacities and on the date indicated.
Signature | Title | Date | ||
/s/ Evan M. Levine
|
Chief Executive Officer and President and Director (Principal Executive Officer) |
June 25, 2008 | ||
/s/ Mark N.K. Bagnall
|
Chief Financial Officer and Executive Vice
President and Director (Principal Financial and Accounting Officer) |
June 25, 2008 | ||
/s/ Jack Lief
|
Chair of the Board | June 25, 2008 | ||
/s/ Alexander J. Denner |
Director | June 25, 2008 | ||
/s/ Michael M. Goldberg
|
Director | June 25, 2008 | ||
8
Table of Contents
Signature | Title | Date | ||
/s/ Mark J. Pykett
|
Director | June 25, 2008 | ||
/s/ Eric K. Rowinsky
|
Director | June 25, 2008 |
9
Table of Contents
INDEX TO EXHIBITS
Exhibit | ||
Number | Description | |
4.1(1)
|
Form of Registration Rights Agreement entered into in October and November 2001 (including the original schedule of holders) | |
4.2(2)
|
$2.50 Warrant to Purchase Common Stock issued on April 12, 2002 to Emisphere Technologies, Inc. | |
4.3(1)
|
Form of $0.60 Warrant to Purchase Common Stock issued May 28, 2003 (including the original schedule of holders) | |
4.4(1)
|
Form of $1.25 Warrant to Purchase Common Stock issued between October 15, 2003 and December 29, 2003 (including the original schedule of holders) | |
4.5(1)
|
Common Stock and Warrant Purchase Agreement, dated as of April 5, 2004, among the Registrant and the Investors (as defined therein) | |
4.6(1)
|
Registration Rights Agreement, dated April 5, 2004, among the Registrant and the Investors (as defined therein) | |
4.7(1)
|
Form of $2.00 A-1 Warrant to Purchase Common Stock issued April 8, 2004 (including the original schedule of holders) | |
4.8(1)
|
Form of $2.50 A-2 Warrant to Purchase Common Stock issued April 8, 2004 (including the original schedule of holders) | |
4.9(3)
|
Common Stock and Warrant Purchase Agreement, dated April 8, 2004, between the Registrant and CD Investment Partners, Ltd. | |
4.10(3)
|
Registration Rights Agreement, dated April 8, 2004, between the Registrant and CD Investment Partners, Ltd. | |
4.11(3)
|
$2.00 A-1 Warrant to Purchase Common Stock issued on April 8, 2004 to CD Investment Partners, Ltd. | |
4.12(3)
|
$2.00 A-1 Warrant to Purchase Common Stock issued on April 8, 2004 to Burnham Hill Partners | |
4.13(3)
|
$2.00 A-1 Warrant to Purchase Common Stock issued on April 8, 2004 to Ernest Pernet | |
4.14(3)
|
$2.00 A-1 Warrant to Purchase Common Stock issued on April 8, 2004 to W.R. Hambrecht + Co., LLC | |
4.15(4)
|
Common Stock and Warrant Purchase Agreement, dated April 19, 2004, between the Registrant and Franklin M. Berger | |
4.16(4)
|
Registration Rights Agreement, dated April 19, 2004, between the Registrant and Franklin M. Berger | |
4.17(4)
|
$2.00 A-1 Warrant to Purchase Common Stock issued on April 19, 2004 to Franklin M. Berger | |
10
Table of Contents
Exhibit | ||
Number | Description | |
4.18(5)
|
Securities Purchase Agreement, dated July 21, 2005, among the Registrant and the Purchasers (as defined therein) | |
4.19(5)
|
Rights Agreement, dated July 27, 2005, among the Registrant, the Icahn Purchasers and Viking (each as defined therein) | |
4.20(6)
|
First Amendment to Rights Agreement, dated September 22, 2006, among the Registrant and the Icahn Purchasers (as defined therein) | |
4.21(7)
|
Second Amendment to Rights Agreement, dated February 25, 2008, among the Registrant and the Icahn Purchasers (as defined therein) | |
4.21(5)
|
Form of $2.26 Common Stock Warrant issued on July 27, 2005 (including the original schedule of holders) | |
4.22(5)
|
Form of $2.26 Common Stock Warrant issued on July 27, 2005 (including the original schedule of holders) | |
4.23(8)
|
$0.50 Warrant (WC-291) to Purchase Common Stock transferred on June 15, 2005 to S. Neborsky and R Neborsky TTEE Robert J. Neborsky MD Inc Comb Retirement Trust | |
4.24(9)
|
$0.50 Warrant (WC-292) to Purchase Common Stock transferred on June 15, 2005 to S. Neborsky and R Neborsky TTEE Robert J. Neborsky MD Inc Comb Retirement Trust | |
4.25(9)
|
$2.50 Warrant to Purchase Common Stock issued on October 22, 2004 to Thomas J. DePetrillo | |
5.1
|
Opinion of DLA Piper US LLP | |
23.1
|
Consent of DLA Piper US LLP (included in Exhibit 5.1) | |
23.2
|
Consent of J.H. Cohn LLP, Independent Registered Public Accounting Firm | |
24.1
|
Powers of Attorney (included on signature page) | |
99.1#(8)
|
2005 Equity Incentive Plan | |
99.2#(10)
|
Form of Stock Option Agreement under the 2005 Equity Incentive Plan | |
99.3#(11)
|
Form of Stock Option Agreement under the 2005 Equity Incentive Plan (for director option grants beginning in 2008) | |
99.4#(12)
|
Form of Restricted Share Award Agreement under the 2005 Equity Incentive Plan | |
99.5#(13)
|
Form of Stock Option Agreement under the 2005 Equity Incentive Plan (for option grants to employees approved in March 2008) | |
99.6#(10)
|
2005 Employee Stock Purchase Plan | |
99.7#(10)
|
Form of Subscription Agreement under the 2005 Employee Stock Purchase Plan | |
99.8#(14)
|
2008 Omnibus Incentive Plan |
(1) | Filed with the Registrants Registration Statement on Form S-3 on June 30, 2004 (SEC file number 333-117022-03848890). |
11
Table of Contents
(2) | Filed with the Registrants Amendment No. 1 to Quarterly Report on Form 10-Q/A on October 30, 2006 (SEC file number 001-32157-061170484). | |
(3) | Filed with the Registrants Current Report on Form 8-K/A on April 13, 2004 (SEC file number 000-33219-04730584). | |
(4) | Filed with the Registrants Quarterly Report on Form 10-QSB on May 12, 2004 (001-32157-04797806). | |
(5) | Filed with the Registrants Quarterly Report on Form 10-Q on August 12, 2005 (SEC file number 001-32157-051022046). | |
(6) | Filed with the Registrants Current Report on Form 8-K on September 22, 2006 (SEC file number 001-32157-061103268). | |
(7) | Filed with the Registrants Current Report on Form 8-K on February 25, 2008 (SEC file number 001-32157-08638638). | |
(8) | Filed with the Registrants Annual Report on Form 10-K on March 15, 2007 (SEC file number 001-32157-07697283). | |
(9) | Filed with the Registrants Registration Statement on Form S-3 on August 26, 2005 (SEC file number 333-127857-051050073). | |
(10) | Filed with the Registrants Registration Statement on Form S-8 on July 13, 2005 (SEC file number 333-126551-05951362). | |
(11) | Filed with the Registrants Annual Report on Form 10-K on March 17, 2008 (SEC file number 001-32157-08690952). | |
(12) | Filed with the Registrants Annual Report on Form 10-K on March 16, 2006 (SEC file number 001-32157-06693266). | |
(13) | Filed with the Registrants Quarterly Report on Form 10-Q on May 12, 2008 (SEC file number 001-32157-08820541). | |
(14) | Filed with the Registrants Current Report on Form 8-K on June 2, 2008 (SEC file number 001-32157- 08874724). | |
# | Indicates management contract or compensatory plan. |
12
EXHIBIT 5.1
June 25, 2008
ADVENTRX Pharmaceuticals, Inc.
6725 Mesa Ridge Road, Suite 100
San Diego, California 92121
6725 Mesa Ridge Road, Suite 100
San Diego, California 92121
Ladies and Gentlemen:
We have acted as legal counsel for ADVENTRX Pharmaceuticals, Inc., a Delaware corporation (the
Company), in connection with a registration statement on Form S-8 (the Registration Statement)
to register under the Securities Act of 1933, as amended (the Securities Act), a total of
16,054,510 shares of the Companys common stock, $0.001 par value per share (the Shares), (i) up
to 783,376 of which may be issued pursuant to the Companys 2005 Equity Incentive Plan (the 2005
EIP), (ii) up to 2,173,634 of which may be issued pursuant to the Companys 2005 Employee Stock
Purchase Plan (the 2005 ESPP), and (iii) up to 13,097,500 of which may be issued pursuant to the
Companys 2008 Omnibus Incentive Plan (the 2008 OIP).
We have examined all instruments, documents and records which we deemed relevant and necessary for
the basis of our opinion hereinafter expressed. In such examination, we have assumed the
genuineness of all signatures and the authenticity of all documents submitted to us as originals
and the conformity to the originals of all documents submitted to us as copies. We express no
opinion concerning any law other than the corporation law of the State of Delaware and the federal
law of the United States. As to matters of Delaware corporation law, we have based our opinion
solely upon our examination of such laws and the rules and regulations of the authorities
administering such laws, all as reported in standard, unofficial compilations.
Based on such examination, we are of the opinion that the Shares, which may be issued pursuant to
awards granted under the 2005 EIP or 2008 OIP or in connection with participation in the 2005 ESPP,
are duly authorized and, when issued against receipt of the consideration therefor in accordance
with the provisions of the 2005 EIP, the 2005 ESPP or the 2008 OIP, as applicable, will be validly
issued, fully paid and nonassessable.
We hereby consent to the filing of this opinion as an exhibit to the Registration Statement and the
use of our name wherever it appears in the Registration Statement. In giving this consent, we do
not admit that we are within the category of persons whose consent is required under Section 7 of
the Securities Act, the rules and regulations of the Securities and Exchange Commission promulgated
thereunder or Item 509 of Regulation S-K.
This opinion letter is given to you solely for use in connection with the issuance of the Shares in
accordance with the Registration Statement and is not to be relied upon for any other purpose. Our
opinion is expressly limited to the matters set forth above, and we render no opinion, whether by
implication or otherwise, as to any other matters relating to the Company, the Shares or the
Registration Statement.
Respectfully submitted, | ||
/s/ DLA Piper US LLP | ||
DLA PIPER US LLP |
13
EXHIBIT 23.2
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in this Registration Statement on Form S-8 of our
reports dated March 14, 2008 (which express an unqualified opinion and include an explanatory
paragraph related to the adoption of Financial Accounting Standards Board Staff Position on No.
EITF 00-19-2, Accounting for Registration Payment Arrangements) with respect to our audits of the
consolidated financial statements of ADVENTRX Pharmaceuticals, Inc. and Subsidiaries and the
effectiveness of ADVENTRX Pharmaceuticals, Inc. and Subsidiaries internal control over financial
reporting as of December 31, 2007, included in its Annual Report (Form 10-K) for the year ended
December 31, 2007 filed with the Securities and Exchange Commission. This Registration Statement
relates to the registration of a total of 16,054,510 shares of common stock of ADVENTRX
Pharmaceuticals, Inc.
/s/ J.H. Cohn LLP
|
San Diego, California
June 23, 2008
June 23, 2008